Page last updated: 2024-08-24

simendan and 1-methyl-3-isobutylxanthine

simendan has been researched along with 1-methyl-3-isobutylxanthine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ajiro, Y; Hagiwara, N; Kasanuki, H; Katsube, Y; Sperelakis, N	1

Other Studies

1 other study(ies) available for simendan and 1-methyl-3-isobutylxanthine

Article	Year
Levosimendan increases L-type Ca(2+) current via phosphodiesterase-3 inhibition in human cardiac myocytes. European journal of pharmacology, 2002, Jan-18, Volume: 435, Issue:1 Topics: 1-Methyl-3-isobutylxanthine; 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Calcium Channels, L-Type; Cyclic Nucleotide Phosphodiesterases, Type 3; Electrophysiology; Heart Atria; Humans; Hydrazones; Myocardium; Phosphodiesterase Inhibitors; Pyridazines; Rabbits; Simendan	2002

Article

Year

Levosimendan increases L-type Ca(2+) current via phosphodiesterase-3 inhibition in human cardiac myocytes.

European journal of pharmacology, 2002, Jan-18, Volume: 435, Issue:1

Topics: 1-Methyl-3-isobutylxanthine; 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Calcium Channels, L-Type; Cyclic Nucleotide Phosphodiesterases, Type 3; Electrophysiology; Heart Atria; Humans; Hydrazones; Myocardium; Phosphodiesterase Inhibitors; Pyridazines; Rabbits; Simendan

2002